FDA-approved CellSearchTM system depends on EpCAM-specific capturing of CTCs in various cancers [21, 30, 47, 49, 125, 127, 258–262]Loss of EpCAM on CTCs as a result of dynamic phenotypic changes during EMT[11, 35, 150, 151, 263]. This evidence concerns the gene EPCAM and cancer.